Improving the quality of life of persons with intellectual disabilities and their families
Staying healthy in a rapidly changing society
Funding Amount
€6.0M - €8.0M
Deadline
16/09/2025
Eligible Organization Types
Non-profit, Private Business, Research Institution, Public Institution
Trusted by
What is the Improving the quality of life of persons with intellectual disabilities and their families Call?
Grant Description
This Horizon Europe research and innovation action supports human-centred research to improve the quality of life, autonomy and independence of persons with long-term intellectual disabilities and their families. It addresses WHO ICD-11 defined disorders of intellectual development through innovative medical, technological, digital or other solutions for early diagnosis, prevention of worsening, treatment, rehabilitation, integrated care strategies and empowerment of persons and carers. Funded p...
Required Results for Successful Funding
Expected Outcomes
Proposals should deliver results that contribute to one or more of the following:
• Persons with intellectual disabilities and their families enjoy improved quality of life, greater empowerment and increased independence through support from innovative research.
• The scientific community develops new medical, technological, digital or other solutions to reverse and/or reduce the severity of intellectual disabilities at the earliest possible stage—especially in children—thereby enhancing health, autonomy and reducing caregiver burden.
• Policymakers, health and care services, patient organisations, funders, the scientific community and other relevant bodies are informed of research advances and best practices addressing the health and needs of persons with intellectual disabilities, ultimately reducing the impact of these disabilities on individuals, families and society.
• Persons with intellectual disabilities and their families enjoy improved quality of life, greater empowerment and increased independence through support from innovative research.
• The scientific community develops new medical, technological, digital or other solutions to reverse and/or reduce the severity of intellectual disabilities at the earliest possible stage—especially in children—thereby enhancing health, autonomy and reducing caregiver burden.
• Policymakers, health and care services, patient organisations, funders, the scientific community and other relevant bodies are informed of research advances and best practices addressing the health and needs of persons with intellectual disabilities, ultimately reducing the impact of these disabilities on individuals, families and society.
Funded areas
Scope Requirements
Proposals must:
• Address one or more intellectual developmental disorders as defined in WHO ICD-11 (codes 6A00, 20 Developmental anomalies), including LD 40 (complete trisomies), LD 90 (conditions with intellectual developmental features), and autism spectrum disorder subtypes 6A02.1, 6A02.3, 6A02.5.
• Focus on persons with long-term intellectual disabilities and their formal and informal carers (including aging family members) in a human-centred manner.
• Aim to improve quality of life, empowerment and independence, and to minimize daily life impact by preventing disease worsening or reducing disability severity.
• Tackle several of the specified research areas (early diagnosis, medical/technological interventions, comorbidity management, transitional care, empowerment, assistive solutions, care services, integrated care, caregiver training).
• Incorporate sex and gender analyses to identify and address diagnostic biases and differential treatment needs.
• Ensure any health technology or medical intervention complies with relevant regulatory requirements and is grounded in robust scientific evidence.
• Include effective contributions from Social Sciences and Humanities disciplines.
• Allocate budget and planning for participation in networking and joint activities.
• If clinical studies are envisaged, provide full study details in the dedicated annex at Stage 2 using the system template.
• Address one or more intellectual developmental disorders as defined in WHO ICD-11 (codes 6A00, 20 Developmental anomalies), including LD 40 (complete trisomies), LD 90 (conditions with intellectual developmental features), and autism spectrum disorder subtypes 6A02.1, 6A02.3, 6A02.5.
• Focus on persons with long-term intellectual disabilities and their formal and informal carers (including aging family members) in a human-centred manner.
• Aim to improve quality of life, empowerment and independence, and to minimize daily life impact by preventing disease worsening or reducing disability severity.
• Tackle several of the specified research areas (early diagnosis, medical/technological interventions, comorbidity management, transitional care, empowerment, assistive solutions, care services, integrated care, caregiver training).
• Incorporate sex and gender analyses to identify and address diagnostic biases and differential treatment needs.
• Ensure any health technology or medical intervention complies with relevant regulatory requirements and is grounded in robust scientific evidence.
• Include effective contributions from Social Sciences and Humanities disciplines.
• Allocate budget and planning for participation in networking and joint activities.
• If clinical studies are envisaged, provide full study details in the dedicated annex at Stage 2 using the system template.
Additional Conditions for Applicants
Special Conditions
- Two-stage submission under a blind evaluation pilot: Stage 1 evaluated anonymously on Excellence and Impact (threshold 4 each; overall budget-based selection), Stage 2 adding Implementation (threshold 4; cumulative 12).
• Lump Sum Grant (HORIZON-AG-LS) under Horizon Europe for Research and Innovation Actions (RIA).
• Eligible participants: legal entities from EU Member States, Horizon Europe Associated Countries (per Annex B), and US entities; must meet Annex C exclusion and capacity criteria.
• Proposal page limits and layout per Part B of the Application Form; anonymity requirements in abstracts and Part B for Stage 1.
• Use of Copernicus and/or Galileo/EGNOS mandatory if projects require satellite-based data.
• Detailed budget table with cost estimates required to justify the lump sum; predefined project budgets: €6–8 million.
• Must comply with Horizon Europe General Annexes A–G (admissibility, evaluation, legal/financial setup).
• Include budget for regular joint meetings; other joint activity costs may be covered without detailed workplans at submission.
• Applicants invited to Stage 2 with clinical studies must complete the clinical studies annex using the provided template.
• Projects are encouraged to explore synergies with other Horizon Europe projects (Clusters 1 and 2) and participate in joint workshops and communication activities.
• Lump Sum Grant (HORIZON-AG-LS) under Horizon Europe for Research and Innovation Actions (RIA).
• Eligible participants: legal entities from EU Member States, Horizon Europe Associated Countries (per Annex B), and US entities; must meet Annex C exclusion and capacity criteria.
• Proposal page limits and layout per Part B of the Application Form; anonymity requirements in abstracts and Part B for Stage 1.
• Use of Copernicus and/or Galileo/EGNOS mandatory if projects require satellite-based data.
• Detailed budget table with cost estimates required to justify the lump sum; predefined project budgets: €6–8 million.
• Must comply with Horizon Europe General Annexes A–G (admissibility, evaluation, legal/financial setup).
• Include budget for regular joint meetings; other joint activity costs may be covered without detailed workplans at submission.
• Applicants invited to Stage 2 with clinical studies must complete the clinical studies annex using the provided template.
• Projects are encouraged to explore synergies with other Horizon Europe projects (Clusters 1 and 2) and participate in joint workshops and communication activities.
Important dates
Open from: 22/05/2025
Deadline:16/09/2025
Application period has ended
Win your grant with Cogrant
How cogrant works
Smart Funding Fit Check
Instantly know if your project fits call criteria. Our system highlights strengths, gaps, and risks, so you only apply when your chances are real.
Intelligent Research Engine
Our research engine digs deeper than any founder could alone. It pulls data about your company, your market, and even your competitors - giving your proposal an edge backed by facts, not fluff.
Full Proposal Development
Our system builds your entire proposal from start to finish, ensuring every section is complete, coherent, and crafted to the highest quality. You focus on your vision — we deliver the winning document.
Expert Review
Our experts run a complete review before delivery, ensuring your draft proposal is accurate, well-structured, and polished. You’ll receive a high-quality draft that’s ready for your final touches before submission.
Our Numbers
Results that speak for themselves
70+
proposals prepared
€36.7M
total funding secured for clients
65%
win rate in highly competitive calls